Uncategorized
Noveome Biotherapeutics, Inc. Publishes Preclinical Results Demonstrating Neuroprotective Properties of ST266 Require Full Complement of Proteins
PITTSBURGH--(BUSINESS WIRE)--Noveome Biotherapeutics has published preclinical results evaluating the neuroprotective properties of its ST266 therapeutic in the journal PLOS ONE.